Cargando…
Allopregnanolone suppresses diabetes-induced neuropathic pain and motor deficit through inhibition of GABA(A) receptor down-regulation in the spinal cord of diabetic rats
OBJECTIVE(S): Painful diabetic neuropathy is associated with hyperexcitability and hyperactivity of spinal cord neurons. However, its underlying pathophysiological mechanisms have not been fully clarified. Induction of excitatory/inhibitory neurotransmission imbalance at the spinal cord seems to acc...
Autores principales: | Afrazi, Samira, Esmaeili-Mahani, Saeed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069843/ https://www.ncbi.nlm.nih.gov/pubmed/24967058 |
Ejemplares similares
-
Allopregnanolone Enhances GABAergic Inhibition in Spinal Motor Networks
por: Drexler, Berthold, et al.
Publicado: (2020) -
Abscisic acid interplays with PPARγ receptors and ameliorates diabetes-induced cognitive deficits in rats
por: Kooshki, Razieh, et al.
Publicado: (2021) -
PKCε and allopregnanolone: functional cross-talk at the GABA(A) receptor level
por: Puia, Giulia, et al.
Publicado: (2015) -
Oxytocin Relieves Neuropathic Pain Through GABA Release and Presynaptic TRPV1 Inhibition in Spinal Cord
por: Sun, Wuping, et al.
Publicado: (2018) -
Activation of GABA(B) Receptor Suppresses Diabetic Neuropathic Pain through Toll-Like Receptor 4 Signaling Pathway in the Spinal Dorsal Horn
por: Liu, Peng, et al.
Publicado: (2018)